Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726591 | SCV000701676 | uncertain significance | not provided | 2016-10-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000726591 | SCV002244590 | pathogenic | not provided | 2024-12-13 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 140 of the BEST1 protein (p.Leu140Val). This variant is present in population databases (rs267606678, gnomAD 0.02%). This missense change has been observed in individuals with clinical features of autosomal recessive bestrophinopathy (PMID: 19853238, 32239196). ClinVar contains an entry for this variant (Variation ID: 2750). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt BEST1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects BEST1 function (PMID: 19853238, 21330666, 24560797). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000002875 | SCV000023033 | pathogenic | Retinitis pigmentosa 50 | 2009-11-01 | no assertion criteria provided | literature only | |
Department of Clinical Genetics, |
RCV000787540 | SCV000926514 | pathogenic | Retinal dystrophy | 2018-04-01 | no assertion criteria provided | research |